Close Menu

Eric Rasmussen, Bryan Baldasare

Jun 25, 2019

Meridian Bioscience has announced that Eric Rasmussen has resigned his position as executive vice president and CFO effective June 28, 2019 in order to pursue other opportunities. Meridian has appointed Bryan Baldasare, currently its senior vice president, corporate controller, treasurer, and chief accounting officer, to serve as interim CFO.

More Like This

Jul 22, 2019

Hologic: Kevin Thornal

Marlborough, Massachusetts-based Hologic said in a filing with the US Securities and Exchange Commission that effective July 29, it has appointed Kevin Thornal, the president of its medical aesthetics division, as president of its diagnostics division.

Jul 18, 2019

Tristan Orpin, Randy Armant, Richard Shippy, Sascha Drewlo

NIPT startup Cradle Genomics of San Diego announced its management team this week.

Tristan Orpin is the firm's CEO. Previously, he was chief commercial officer and executive VP of clinical genomics at Illumina. Prior to that, he held executive positions at Sequenom and at Bio-Rad Laboratories. Orpin has a BSc in genetics and biochemistry from the University of Melbourne.

Randy Armant is a cofounder and the firm's VP of research. He is a professor of obstetrics and gynecology at Wayne State University. Armant holds a PhD in developmental biology and biochemistry from Virginia Tech.

Richard Shippy is a cofounder and the company's VP of commercial. Previously, he was the senior director of strategic product marketing in reproductive and genetic health at Illumina. Before that, he held management positions in clinical market development at Affymetrix and at GE Healthcare. Shippy holds an MSc in biochemistry from Northern Illinois University.

Sascha Drewlo is a cofounder and Cradle's VP of development. He holds a PhD in molecular and cell biology from the German Sport University Cologne and an MSc in microbiology and genetics from the University of Münster.

Jul 18, 2019

Sam Samad

Westbrook, Maine-based Idexx Laboratories has appointed Sam Samad to its board of directors. Samad currently serves as senior VP and CFO at Illumina. Prior to joining Illumina, Samad held multiple senior leadership positions at Cardinal Health from 2009 to 2017, including senior VP and corporate treasurer. 

Jul 18, 2019

Mark McClellan

San Francisco-based life science and health data firm Seer has appointed Mark McClellan to its board of directors. McClellan currently serves as a professor of business, medicine, and health policy at Duke's Duke-Margolis Center for Health Policy. Prior to Duke, McClellan served as administrator of the Centers for Medicare & Medicaid Services and commissioner at the US Food and Drug Administration. 

Jul 18, 2019

Kirk Wojno

OncoCell MDx, an immunogenomics company developing noninvasive molecular diagnostic assays, has named Kirk Wojno as chief medical officer. Wojno is former head of urologic pathology at the University of Michigan; at Ascension Health System; and AmeriPath, a division of Quest Diagnostics. He has more than 30 years in medical practice and most recently served as the chief of pathology and laboratory services and director of cinical research for the Comprehensive Urology practice in Royal Oak, Michigan.

Jul 17, 2019

J. Wallace Parce

Ontera, a Santa Cruz, California-based firm developing silicon-based nanopore diagnostics, has appointed J. Wallace Parce to its advisory board. He has cofounded and held senior positions at a number of life science technology companies including Nanosys, Caliper Technologies, and Molecular Devices. 

Parce was an associate professor at Wake Forest University's medical school and also received his doctorate from that university.

Jul 12, 2019

Alexander Mackinnon

Alexander “Craig” Mackinnon has become the inaugural director of the Division of Genomics, Diagnostics, and Bioinformatics in the Department of Pathology at the University of Alabama at Birmingham School of Medicine. He will lead ongoing efforts to establish a Precision Diagnostic Laboratory at UAB. 

Mackinnon is a board-certified anatomical and molecular genetic pathologist. Previously, he was associate professor in the Department of Pathology at the Medical College of Wisconsin, where he directed the Clinical and Translational Research Laboratory, which developed multiple sequencing-based panels targeting variants in both DNA and RNA. 

Jul 10, 2019

Keng Hsu

Keng Hsu has stepped down from the board of Yourgene to improve the balance of executive and non-executive directors and to allow him to focus on business development in Asia. Yourgene plans to add non-executive directors to its board in the near future.

Jul 09, 2019

Christopher Thibodeau

OncoCell MDx has appointed Christopher Thibodeau as chief operating officer. Prior to OncoCell MDx, Thibodeau served as COO at MDxHealth. Before MDxHealth, he held various positions at Agendia, Numira Biosciences, LabCorp's US LABS, and Roche Diagnostics' Ventana Medical Systems 

Jul 03, 2019

Steven Averbuch

Steven Averbuch has joined Caris Life Sciences' scientific advisory board. Averbuch recently retired from the role of vice president and head of precision medicine in the translational medicine division of R&D at Bristol-Myers Squibb. During his tenure, Averbuch spearheaded the Pharmacodiagnostics Center of Excellence, which led to the application of BMS' precision medicine strategy across all therapeutic areas. Prior to this, Averbuch oversaw corporate-wide strategic initiatives for translational and targeted medicine at BMS. He also served as head of early global clinical research at the company. Averbuch also previously held leadership roles with Merck Research Laboratories and AstraZeneca, and held academic appointments at Mount Sinai School of Medicine and the US Public Health Service School of Medicine.

Jul 03, 2019

Jonathan Genzen

ARUP Laboratories appointed Jonathan Genzen as its chief operating officer effective July 1. Genzen has held a number of positions since starting at ARUP in January 2013. He served as its chemistry section chief and medical director for its automated core laboratory, laboratory automation, and Farmington clinical laboratory, among other responsibilities. Prior to joining ARUP, Genzen was a faculty member in the Department of Pathology and Laboratory Medicine at Weill Cornell Medical College.

Jul 02, 2019

Troy Cox

Troy Cox has joined Sophia Genetics' board of directors. Cox previously was CEO of Foundation Medicine, which was acquired by Roche last year. Prior to that he was senior vice president and an officer at Genentech. He has also held executive and senior positions with UCB BioPharmaceuticals, Sanofi-Aventis, and Schering-Plough.

Jul 02, 2019

Grace Colón

CareDx has appointed Grace Colón to its board of directors.  Colón currently served as president, CEO, and director of InCarda Therapeutics. She is also executive chairman of ProterixBIo and is on the board of Cocoon Biotech. Colón previously served on the boards of Paradigm Diagnostics and PerceptiMed. Colón has also served as a partner at New Science Ventures and held various leadership roles at Intrexon, Gilead Sciences, and Affymetrix. She will succeed Amy Abernethy on CareDx's board. 

Jul 01, 2019

David Rubin, Timothy Harris

David Rubin and Timothy Harris informed OpGen that they would be leaving the company's board, effective June 30. OpGen disclosed the resignations in a document filed with US Securities and Exchange Commission on July 1. Both had been on OpGen's board since 2015. The company said there had been no disagreement with Rubin or Harris leading to their resignations. 

Jul 01, 2019

Keith Kennedy

Veracyte has appointed Keith Kennedy as chief operating officer. Prior to joining Veracyte, Kennedy served as executive leadership positions at MCG Capital, Arlington Capital Partners, and GE Capital over the past 20 years.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.